Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/1996
11/05/1996US5571940 Method for making conjugate moieties capable of chelating paramagnetic metals and designed for coupling with a factor responsive to specific cellular marker sites
11/05/1996US5571842 Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
11/05/1996US5571671 Detection of mosaic population of cells with two or three copies of chromosome 21
11/05/1996US5571505 Anti-HIV oligomers
11/05/1996US5571498 Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI).
11/05/1996US5571497 Pressurization of vessel containing liposome in liquid media followed by rapid depressurization
10/1996
10/31/1996WO1996033747A2 Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents
10/31/1996CA2217390A1 Water soluble fluorinated fatty acid sulfonate derivatives useful as magnetic resonance imaging agents
10/30/1996EP0739337A1 Functionalized macrocyclic ligands for imaging applications
10/30/1996EP0656762A4 Magnetic resonance arteriography with dynamic intravenous contrast agents.
10/30/1996EP0607401B1 Particles for nmr imaging and method of manufacture
10/30/1996EP0571593B1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them
10/30/1996EP0402386B1 Use of two kinds of molecules for providing liposomes with a positive charge
10/29/1996US5569759 Water soluble texaphyrin metal complex preparation
10/29/1996US5569675 Administering to treat blood disorders
10/29/1996US5569449 Biotolerable matrix in association with fluorinated gas, stabilized by presence of cross-linking groups attached to matrix
10/29/1996US5569448 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
10/29/1996US5569446 Therapeutic and diagnostic uses
10/24/1996WO1996032967A1 Hybrid magnetic resonance contrast agents
10/24/1996CA2217718A1 Hybrid magnetic resonance contrast agents
10/23/1996EP0738283A1 New polyaminocarboxylate chelators
10/23/1996EP0738157A1 Contrast media for x-ray and magnetic resonance imaging
10/23/1996EP0629214B1 Chemical compounds
10/23/1996EP0558661B1 Polyazamacrocyclic compounds for complexation of metal ions
10/23/1996EP0416094B1 Parathyroid hypertensive factor
10/23/1996CN1134110A Method for regulating gastrointestinal motility
10/22/1996US5567765 Artificial blood, contrast agent, organ preservative
10/22/1996US5567687 Useful in photodynamic therapy and light-induced cleavage of a polymer of deoxyribonucleic acid
10/22/1996US5567593 Cytodiagnostic method using alstonine as a selective marker, and diagnostic kit containing marker
10/22/1996US5567415 Ultrasound contrast agents and methods for their manufacture and use
10/22/1996US5567414 Image contrast agent
10/22/1996US5567413 Flexible amphiphilic microbubbles for ultrasound
10/22/1996US5567412 Microbubble generating carbohydrate particles mixed with amphiphilic organic acid; ultrasonic or magnetic resonance imaging
10/22/1996US5567411 Dendritic amplifier molecules having multiple terminal active groups stemming from a benzyl core group
10/22/1996US5567410 Compound capable of reversibly forming micelles containing hydrophilic polymer linked to hydrophobic polymer having covelantly bonded radiopaque molecules
10/22/1996US5567409 Administering a tetrapyrrole carboxylic acid in sufficient quantity to accumulate in arthritic lesion; applying light to cause it to produce fluorescence
10/22/1996US5567408 YIGSR peptide radiopharmaceutical applications
10/17/1996WO1996032134A2 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
10/17/1996WO1996032094A1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof
10/17/1996WO1996023526A3 Diagnostic imaging contrast agents with extended blood retention
10/17/1996DE19514087A1 Konjugat aus einem Wirkstoff, einem Polyether und ggfs. einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active ingredient, a polyether and, if necessary, a not as foreign prestigious, native protein
10/16/1996EP0737220A1 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
10/16/1996EP0737209A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
10/16/1996EP0500732B1 Diagnostic composition comprising a binuclear complex, a method for preparing same, and its use in magnetic resonance imaging
10/16/1996CN1133559A photosensibilizers
10/16/1996CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
10/15/1996US5565552 Method of expanded porphyrin-oligonucleotide conjugate synthesis
10/15/1996US5565215 Biodegradable injectable particles for imaging
10/15/1996US5565187 Methods for studying capillary circulation using fish fry and tadpoles
10/15/1996US5565186 Transgenic mouse having genome comprised of native mouse gene having some codons replaced with corresponding human codons, rendering mouse susceptible to infection with prions which cause disease in humans
10/15/1996US5565184 Administering as contrast agent stable complex with good relaxivity and osmolar characteristics
10/10/1996WO1996031537A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996WO1996031196A1 Novel compositions of lipids and stabilizing materials
10/10/1996WO1996020735A3 Oral gastrointestinal x-ray contrast agents in combination with surfactants
10/10/1996WO1996020734A3 Oral gastrointestinal x-ray contrast agents in combination with pharmaceutically acceptable clays and surfactants
10/10/1996DE19511610A1 Verfahren und Vorrichtung zur Bestimmung des zirkulierenden Blutvolumens eines lebenden Organismus Method and apparatus for determining the circulating blood volume of a living organism
10/10/1996CA2217572A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/09/1996EP0736059A1 Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents
10/09/1996EP0736056A1 Cascade polymers with iodine aromatic compounds
10/09/1996EP0736035A1 Pretargeting methods and compounds
10/09/1996EP0735900A1 Paramagnetic diagnostic formulations and their method of use
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0517740B1 Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/09/1996CN1132743A Prepn of contrast medium 'Dianhaichun'
10/08/1996US5562894 Complexes for magnetic resonance imaging contrast agents
10/08/1996US5562893 Gas-filled microspheres with fluorine-containing shells
10/08/1996US5562099 Polymeric microparticles containing agents for imaging
10/03/1996WO1996030053A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996029931A1 Process and device for determining the volume of blood circulating in a living organism
10/03/1996WO1996024381A3 Liposomes containing contrast media for blood pool imaging
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2215836A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/02/1996EP0735040A2 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734268A1 Xenogeneic tissue implant in ear pinna
10/02/1996EP0275285B1 Biodegradable superparamagnetic materials used in clinical applications
10/01/1996US5561226 Process for the production of a pyrogen-free fructan which is readily water-soluble
10/01/1996US5561043 Genetic engineering
10/01/1996US5560933 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
10/01/1996US5560932 Dissolving pharmaceutical in aqueous base, adding aqueous solution of surface modifier, neutralizing alkaline solution with acid to form dispersion
10/01/1996US5560903 Method of enhancing paramagnetism in chelates for MRI
10/01/1996US5560902 Microfluidization of radioactive calcium/oxyanion-containing particles
10/01/1996US5560364 Suspended ultra-sound induced microbubble cavitation imaging
10/01/1996CA1338617C Magnetic resonance imaging with perfluorocarbon hydrides
09/1996
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1995010217A3 Functionalized aza-cryptand ligands for imaging applications
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation
09/25/1996EP0732939A1 Preparation and use of immunoconjugates
09/25/1996EP0721311A4 Second sphere complexes as relaxation agents for image enhancement in magnetic resonance imaging
09/25/1996EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
09/25/1996EP0222886B1 Hepatobiliary nmr contrast agents
09/24/1996US5559266 Injectable contrast medium for x-rays or ultrasound images
09/24/1996US5559207 Texaphyrin metal complex mediated ester hydrolysis
09/24/1996US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof
09/24/1996US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies
1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 354